MFMU NETWORK (COLUMBIA UNIV. FACULTY @ SLRH AND CPMC)

随附的申请建议，纽约市哥伦比亚大学医学中心的母胎医学部门，包括圣卢克罗斯福医疗中心（及其连续伙伴关系附属贝斯以色列医疗中心）和哥伦比亚长老会医院中心，被选为多中心合作母胎单位网络（MFMU）的新成员。我们的医院位于纽约大都会地区的战略位置。它们与各自的周边社区密切相关，从而能够有针对性地改善医疗保健服务，在患者和医疗保健提供者之间建立可靠的关系，从而创造有利于招募患者参加临床试验的环境。每年有15000多名来自不同社会、经济、民族、种族和文化背景的初级和转诊患者在我们的医院接受治疗，其中30%以上是高危患者。我们机构的母胎医学部门的教师代表了一个高度积极的个人团队，他们热情地接近成为MFMU网络新研究中心的前景。他们是经验丰富的研究人员，在招募和留住临床试验的受试者方面非常成功。该学院拥有成功申请拨款和授予合同的记录。我们目前作为独立中心参与了MFMU BEAM研究（硫酸镁有益作用的随机临床试验），并作为Thomas Jefferson大学的附属机构参与了另外两项MFMU研究。哥伦比亚大学的妇产科目前在美国国立卫生研究院的妇产科资助方面排名全国第二，也是FASTER试验的主要中心。圣卢克-罗斯福医院中心、哥伦比亚长老会中心、贝斯以色列医疗中心的教职员工和他们的管理部门一致渴望参与MFMU的试验，并强烈支持这项拨款申请。

The attached application proposes that the Maternal-Fetal Medicine Division of the Columbia University Medical Centers in New York City including St. Luke's-Roosevelt Medical Center (with it's Continuum partnership affiliate Beth Israel Medical Center) and Columbia Presbyterian Hospital Center be selected as a new member for the Cooperative Multicenter Network of Maternal Fetal Units (MFMU). Our hospitals are strategically placed throughout the Metropolitan New York area. They are closely associated with the respective surrounding communities, thus allowing targeted and improved delivery of Health Care, dependable relationships between patients and health care providers, and thereby creating an environment that facilitates patient recruitment to clinical trials. Over 15,000 primary and referral patients who represent a broad spectrum of social, economic, ethnic, racial and cultural backgrounds deliver in our facilities each year of whom more than 30% are high risk. The faculty of the Divisions of Maternal-Fetal Medicine in our institutions represents a team of highly motivated individuals who are enthusiastically approaching the prospect of becoming a new study center for the MFMU network. They are experienced investigators who have been highly successful in recruiting and retaining subjects in clinical trials. The faculty have a record of successful grant applications and contract awards. We are currently participating as an independent Center in the MFMU BEAM Study (Randomized Clinical Trial of the Beneficial Effects of Magnesium Sulfate) and as an affiliate of Thomas Jefferson University in two additional MFMU studies. The Department of OB/GYN at Columbia University currently ranks second place nationally for funding in Obstetrics and Gynecology by the NIH and is the leading center for the FASTER trial. The faculty of the St Luke's-Roosevelt Hospital Center, Columbia Presbyterian Center, Beth Israel Medical Center and their administrations are unanimous in their eagerness to participate in the MFMU trials and strongly support this grant application.